Biotech Values

[DewDiligence]

Also critical of the FDA's actions are Momenta's rivals--including Teva Pharmaceutical Industries Ltd…and Amphastar Pharmaceuticals Inc… Teva officials told the [Wall Street] Journal that the company met with the FDA in October and complained about possible bias. It said its application, which was filed two years before Momenta's, is stuck in bureaucratic limbo, and that it received delayed notice when the FDA changed the terms for evaluating the drugs.

So, Teva acknowledges that its Lovenox application is “stuck in bureaucratic limbo.” I already knew this was true, but to hear Teva admit it is music to my ears!